Tatva Chintan Pharma Chem Limited

NSE:TATVA.NS

856.35 (INR) • At close November 4, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 834.91,054.64982.66842.06966.691,143.641,245.121,206.07900.91884.02961.761,046.71,236.151,068.321,051.65801.17600.43515.32
Kosten van de omzet 427.21763.59620.77373.42373.14580.48750.08677.97434.46398.5542.76451.86550.1532.06634.76321.25336.12262.53
Brutowinst 407.69291.05361.89468.64593.55563.16495.04528.1466.45485.52419594.84686.05536.26416.89479.92264.31252.79
Brutowinstmarge 0.4880.2760.3680.5570.6140.4920.3980.4380.5180.5490.4360.5680.5550.5020.3960.5990.440.491
Onderzoek- en ontwikkelingskosten 00000060.3900037.070007.04000
Algemene en administratieve kosten 000000000000000000
Verkoop- en marketingkosten 000000000000000000
Verkoop-, algemene en administratieve kosten 222.43231.55268.13211.04140.69115.62229.02244.02262.7285.8191.5482.2374.54206.6768.6971.1853.647.59
Overige kosten 419.9511.7345.2812.17.5610.158.4515.215.4918.29-91.647.2428.0413.22-28.926.5519.480
Bedrijfskosten 419.95231.55268.13424.53458.84409.85357.57372.8377.76356.69206.1377.52347.68292.48173.64250.61217.48164.48
Bedrijfsresultaat -12.2659.593.7656.21134.71153.31145.92170.5104.18128.83209.81217.32338.37257250.62235.8466.3186.63
Bedrijfsresultaat ratio -0.0150.0560.0950.0670.1390.1340.1170.1410.1160.1460.2180.2080.2740.2410.2380.2940.110.168
Totaal overige inkomsten en kosten netto 2.058.5943.14-3.77-22.58-19.11-67.86-28.27-13.68.12-20.0537.3615.8-14.39-8.23-11.09-9.87-3.27
Inkomen voor belasting -10.2168.09136.952.44112.13134.278.06142.2390.58136.95189.76254.68354.17242.61242.39224.7556.4483.36
Inkomen voor belasting ratio -0.0120.0650.1390.0620.1160.1170.0630.1180.1010.1550.1970.2430.2870.2270.230.2810.0940.162
Belastingkosten -3.571640.7617.8934.3239.16-91.532619.4638.9814.6626.6130.0511.1531.21620.8816.26
Nettowinst -6.6452.0996.1434.5577.8195.04169.59116.2371.1297.97175.1228.07324.12231.46211.19208.7535.5667.1
Nettowinstmarge -0.0080.0490.0980.0410.080.0830.1360.0960.0790.1110.1820.2180.2620.2170.2010.2610.0590.13
WPA (Winst Per Aandeel) -0.292.234.111.483.434.297.655.243.214.427.910.2915.0210.4410.5110.391.773.34
Verwaterde WPA -0.292.234.111.483.434.297.655.243.214.427.910.2915.0210.4410.5110.391.773.34
EBITDA 59.64126.15156.09122.04210.04223.58171.23194.33127.26170.45217.06285.32386.98275.98268.37251.7583.1597.878
EBITDA ratio 0.0710.120.1590.1450.2170.1950.1380.1610.1410.1930.2260.2730.3130.2580.2550.3140.1380.19